(NASDAQ: ALGN) Align Technology's forecast annual revenue growth rate of 4.71% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Align Technology's revenue in 2025 is $3,999,012,000.On average, 6 Wall Street analysts forecast ALGN's revenue for 2025 to be $300,677,155,897, with the lowest ALGN revenue forecast at $299,589,529,855, and the highest ALGN revenue forecast at $301,919,631,390. On average, 6 Wall Street analysts forecast ALGN's revenue for 2026 to be $317,942,280,946, with the lowest ALGN revenue forecast at $316,212,294,632, and the highest ALGN revenue forecast at $319,873,041,644.
In 2027, ALGN is forecast to generate $338,949,993,591 in revenue, with the lowest revenue forecast at $332,875,538,116 and the highest revenue forecast at $344,284,645,509.